A 3-year-old unvaccinated child from rural India presents with acute epiglottitis, stridor, and drooling. Blood culture grows a gram-negative coccobacillus that requires X and V factors. All of the following are correct regarding this organism EXCEPT:

Explanation

## Haemophilus influenzae Type b Epiglottitis: Clinical Management ### Clinical Presentation & Diagnosis **Key Point:** Acute epiglottitis caused by H. influenzae type b (Hib) is a medical emergency characterized by: - Sudden onset of severe sore throat, dysphagia, drooling - Inspiratory stridor and respiratory distress - "Thumbprint" sign on lateral neck X-ray (swollen epiglottis) - Rapid progression to airway obstruction if untreated **Clinical Pearl:** In unvaccinated children (especially in resource-limited settings), Hib remains a leading cause of invasive disease and epiglottitis, despite global Hib vaccination programs. ### Antibiotic Therapy | Antibiotic | Role | Notes | |------------|------|-------| | **Ceftriaxone** | First-line | 80–100 mg/kg/day IV; covers Hib, meningitis, and resistant strains | | **Cefotaxime** | Alternative | Equivalent efficacy for epiglottitis and meningitis | | **Ampicillin** | NOT recommended | Risk of BLPRO and BLNAR resistance; should not be used empirically | | **Fluoroquinolones** | Adjunct | Levofloxacin for prophylaxis; NOT for acute disease in children | **High-Yield:** Ceftriaxone is given empirically WITHOUT waiting for susceptibility results in life-threatening Hib infections (epiglottitis, meningitis, bacteremia). ### Nasopharyngeal Colonization **Key Point:** Asymptomatic nasopharyngeal colonization with H. influenzae (including type b) is common in the general population, especially in children. Colonization alone does NOT require treatment and does NOT indicate invasive disease. **Clinical Pearl:** The distinction between colonization and invasive disease is critical — treatment is reserved for symptomatic/invasive disease. ### Prophylaxis for Close Contacts ```mermaid flowchart TD A[Invasive Hib disease in index case]:::outcome --> B{Household contacts?}:::decision B -->|Yes: age < 4 years OR immunocompromised| C[Rifampicin prophylaxis indicated]:::action B -->|Yes: age ≥ 4 years, immunocompetent| D[Prophylaxis NOT routinely given]:::action B -->|Childcare/school contacts| E[Assess exposure duration & age]:::decision E -->|Prolonged exposure + age < 4| F[Rifampicin prophylaxis]:::action E -->|Brief exposure| G[No prophylaxis]:::action C --> H[Rifampicin 20 mg/kg/day for 4 days]:::action F --> H ``` **High-Yield:** Rifampicin prophylaxis (20 mg/kg/day for 4 days, max 600 mg/day) is indicated for: - **Household contacts < 4 years old** (vaccinated or unvaccinated) - **Immunocompromised household contacts** of any age - **Childcare/school contacts** with prolonged exposure and age < 4 years **NOT indicated for:** All close contacts universally. Age and immunocompetence determine need. ### Pathogenesis of Invasive Disease **Key Point:** H. influenzae lipopolysaccharide (LPS) is a potent endotoxin that activates Toll-like receptor 4 (TLR-4) on innate immune cells, triggering: - Cytokine release (TNF-α, IL-6, IL-8) - Systemic inflammation and sepsis - Increased vascular permeability (epiglottic edema) - Shock in severe cases